Linked Life Data

10693734

Source:http://linkedlifedata.com/resource/pubmed/id/10693734

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-3-1
pubmed:abstractText
To evaluate the long-term efficacy and tolerability within primary care settings of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1063-3987
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
160-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:10693734-Adult, pubmed-meshheading:10693734-Anti-Obesity Agents, pubmed-meshheading:10693734-Blood Glucose, pubmed-meshheading:10693734-Blood Pressure, pubmed-meshheading:10693734-Cardiovascular Diseases, pubmed-meshheading:10693734-Double-Blind Method, pubmed-meshheading:10693734-Female, pubmed-meshheading:10693734-Humans, pubmed-meshheading:10693734-Insulin, pubmed-meshheading:10693734-Lactones, pubmed-meshheading:10693734-Lipase, pubmed-meshheading:10693734-Lipids, pubmed-meshheading:10693734-Male, pubmed-meshheading:10693734-Middle Aged, pubmed-meshheading:10693734-Obesity, Morbid, pubmed-meshheading:10693734-Primary Health Care, pubmed-meshheading:10693734-Risk Factors, pubmed-meshheading:10693734-Treatment Outcome, pubmed-meshheading:10693734-United States, pubmed-meshheading:10693734-Vitamins, pubmed-meshheading:10693734-Weight Loss
pubmed:year
2000
pubmed:articleTitle
Orlistat in the long-term treatment of obesity in primary care settings.
pubmed:affiliation
Department of International Clinical Research, Hoffman-LaRoche Inc, Nutley, NJ 07110, USA. jonathan.hauptman@roche.com
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study